Session Type
Meeting
Search Results for MI
Abstract Number: 140
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Academic hospitalists aspire to be highly effective teachers and must demonstrate excellence in teaching to be promoted. Internal Medicine (IM) residency programs increasingly rely on such hospitalists to supervise residents when they are on inpatient service. Accordingly, outstanding resident teaching and evaluations are imperative to the advancement of academic hospitalists and the success of […]
Abstract Number: 141
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Hyperkalemia occurs frequently in diabetes. Sodium zirconium cyclosilicate (SZC), an oral, selective potassium (K) binder, rapidly reduces K in patients (pts) with hyperkalemia and has been shown to maintain normokalemia for up to 1 y. We compared the response to SZC in adults with and without diabetes mellitus (DM, type 1/2) in a 12 […]
Abstract Number: 142
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Hepcidin-25 is a liver-derived peptide hormone that regulates iron homeostasis in humans. Recent studies have suggested that it also plays a key role in host-pathogen interface. Iron is essential for the survival and growth of bacteria. When the bacteria infect macrophages, macrophages release a number of cytokines, including interleukin-6, which induce hepatic production of […]
Abstract Number: 143
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Patient & Family Advisory Councils (PFACs) are groups of patients and caregivers who share their overall experiences of care and perspectives on specific topics with hospital leaders at regular meetings. PFACs provide a crucial supplemental layer of feedback to hospitals outside of HCAHPS survey data and post-discharge phone calls. Hospital Medicine specific PFACs are […]
Abstract Number: 144
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Thalidomide, a previously banned sedative drug, was rediscovered as an immunomodulator. Multiple studies demonstrated thalidomide as an experimental treatment for refractory Crohn disease. However, the level of evidence has been limited by the overall inconsistent results. With meta-analysis, we aim to assess the effect of thalidomide and its derivative lenalidomide on refractory Crohn disease […]
Abstract Number: 147
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Large volume paracentesis is commonly performed in patients with refractory ascites but can induce hypotension and kidney injury. There is evidence that administering albumin at 6-8 grams per liter (g/L) of ascites removed during or after paracentesis can reduce these adverse events. Current guidelines recommend this practice when >2 liters are removed in high-risk […]
Abstract Number: 151
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: The Center for Health Evaluations, Education, Research and Engagement (CHEVERE) study is a research program at Lincoln Hospital designed to explore the cultural, social and psychological factors that either facilitate or serve as barriers to behavioral change in the South Bronx community. The focus of our Phase II, non-blinded, prospective study is to develop […]
Abstract Number: 152
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: While prescription opioids have a role in treating certain pain conditions, their injudicious use has led to an epidemic with myriad adverse outcomes. We sought to evaluate the association of socioeconomic and racial disparities with healthcare utilization and outcomes in opioid overdose related hospitalizations using National Inpatient Sample (NIS) database from 2012 through 2014. […]
Abstract Number: 153
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Involvement of a cardiologist in the care of hospitalized patients with a primary diagnosis of heart failure (HF) has been shown to improve outcomes and may affect their readmission rates. However, less is known about the patients admitted for a different reason who carry a secondary diagnosis of HF and the effect of cardiology […]
Abstract Number: 155
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Anemia in patients with heart failure (HF) is common. Data reported shows a variable prevalence ranging from 10-40%. Additionally, it has also been demonstrated that it is associated with poor outcomes. Multiple risk factors have been shown to contribute to the presence of anemia in HF patients. The population of the Rio Grande Valley […]